NO982843L - 2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater - Google Patents

2,7-Substituerte oktahydro-pyrrol£1,2-a|pyrazin-derivater

Info

Publication number: NO982843L
Authority: NO; Norway
Prior art keywords: apyrazine; pyrrole; derivatives; substituted octahydro; octahydro
Prior art date: 1995-12-21

Application number

NO982843A

Other languages

English (en)

Other versions

NO982843D0 (no

NO309936B1 (no

Inventor

Mark A Sanner

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-21

Filing date

1998-06-19

Publication date

1998-06-19

1998-06-19 Application filed by Pfizer filed Critical Pfizer

1998-06-19 Publication of NO982843L publication Critical patent/NO982843L/no

1998-06-19 Publication of NO982843D0 publication Critical patent/NO982843D0/no

2001-04-23 Publication of NO309936B1 publication Critical patent/NO309936B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Psychology (AREA)
Addiction (AREA)
Ophthalmology & Optometry (AREA)
Anesthesiology (AREA)
Nutrition Science (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO982843A 1995-12-21 1998-06-19 2,7-Substituerte oktahydro-pyrrol[1,2-a]pyrazin-derivater, anvendelse derav, farmasøytisk preparat, samt mellomprodukter for fremstilling av derivatene NO309936B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US898895P	1995-12-21	1995-12-21
PCT/IB1996/001192 WO1997023482A1 (en)	1995-12-21	1996-11-06	2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives

Publications (3)

Publication Number	Publication Date
NO982843L true NO982843L (no)	1998-06-19
NO982843D0 NO982843D0 (no)	1998-06-19
NO309936B1 NO309936B1 (no)	2001-04-23

Family

ID=21734893

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO982843A NO309936B1 (no)	1995-12-21	1998-06-19	2,7-Substituerte oktahydro-pyrrol[1,2-a]pyrazin-derivater, anvendelse derav, farmasøytisk preparat, samt mellomprodukter for fremstilling av derivatene

Country Status (33)

Country	Link
US (1)	US5714487A (no)
EP (1)	EP0874849B1 (no)
JP (1)	JP3204456B2 (no)
KR (1)	KR100286786B1 (no)
CN (1)	CN1061350C (no)
AR (1)	AR005102A1 (no)
AT (1)	ATE205846T1 (no)
AU (1)	AU704578B2 (no)
BR (1)	BR9612246A (no)
CA (1)	CA2240594C (no)
CO (1)	CO4480107A1 (no)
CZ (1)	CZ192998A3 (no)
DE (1)	DE69615404T2 (no)
DK (1)	DK0874849T3 (no)
ES (1)	ES2161377T3 (no)
GR (1)	GR3037060T3 (no)
GT (1)	GT199600101A (no)
HU (1)	HUP9900611A3 (no)
IL (1)	IL124453A0 (no)
MA (1)	MA26413A1 (no)
MX (1)	MX9805088A (no)
NO (1)	NO309936B1 (no)
NZ (1)	NZ320537A (no)
PE (1)	PE25998A1 (no)
PL (1)	PL327539A1 (no)
PT (1)	PT874849E (no)
RU (1)	RU2162470C2 (no)
SI (1)	SI0874849T1 (no)
TN (1)	TNSN96164A1 (no)
TR (1)	TR199801161T2 (no)
TW (1)	TW479058B (no)
WO (1)	WO1997023482A1 (no)
ZA (1)	ZA9610781B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6281216B1 (en) *	1998-02-09	2001-08-28	Duphar International Research B.V.	2-aminoquinoline derivatives having d4-agonistic activity
EP0982030A3 (en)	1998-08-17	2000-05-10	Pfizer Products Inc.	2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
PL349912A1 (en) *	1999-02-05	2002-10-07	Upjohn Co	Process to prepare (5r)-(methylamino)-5,6-dihydro-4h-imidazo[4,5,1-ij]-quinolin-2(1h)-one
EP1083369B1 (en)	1999-09-10	2004-06-30	Mitsubishi Jidosha Kogyo Kabushiki Kaisha	Continuously variable transmission
US7253165B2 (en)	1999-09-14	2007-08-07	Aventis Pharmaceuticals Inc.	Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
CZ2002898A3 (cs) *	1999-09-14	2002-07-17	Aventis Pharmaceuticals Inc.	Benzisoxazolyl-, pyridoisoxazolyl- a benzthienylfenoxyderiváty a jejich pouľití jako antagonistů D4
US7091199B1 (en)	1999-09-14	2006-08-15	Aventis Pharmaceuticals Inc.	Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en)	1999-09-14	2006-10-24	Aventis Pharmaceuticals Inc.	Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
DE60211186T2 (de) *	2001-09-19	2007-01-18	Merck Patent Gmbh	Neue verwendung substituierter aminomethylchromane
TW200801005A (en) *	2005-08-15	2008-01-01	Astrazeneca Ab	Acetylenic piperazines as metabotropic glutamate receptor antagonists
US7728031B2 (en) *	2006-02-24	2010-06-01	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole derivatives
US8669255B2 (en) *	2011-09-29	2014-03-11	Abbvie Inc.	Substituted octahydropyrrolo[1,2-a]pyrazines as calcium channel blockers
CA3108076A1 (en)	2018-09-04	2020-03-12	Pipeline Therapeutics, Inc.	Muscarinic acetylcholine m1 receptor antagonists
US11752149B2 (en)	2019-12-02	2023-09-12	Pipeline Therapeutics, Inc.	Muscarinic acetylcholine M1 receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4400511A (en) *	1982-05-07	1983-08-23	American Home Products Corporation	2-Substituted octahydropyrrolo(1,2-A)-pyrazine-3-carboxylic acids
MX19222A (es) *	1989-01-23	1993-12-01	Pfizer	Agentes ansioliticos bis-aza-biciclicos
US5122515A (en) *	1990-06-19	1992-06-16	Smith Ross C	Nutrient composition containing dipeptides and method for administering the same
JP3058945B2 (ja) *	1990-10-26	2000-07-04	三共株式会社	Ｎ−（３，３−ジ置換アクリロイル）ピペラジン誘導体
US5631269A (en) *	1992-10-23	1997-05-20	Merck Sharp & Dohme Limited	Dopamine receptor subtype ligands
US5670522A (en) *	1992-10-23	1997-09-23	Merck Sharp & Dohme Limited	Dopamine receptor subtype ligands
AU703431B2 (en) *	1994-08-05	1999-03-25	Pfizer Inc.	Benzimidazole derivatives having dopaminergic activity
EP0783503B1 (en) *	1994-09-30	2001-11-28	Pfizer Inc.	2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
US5576314A (en) *	1994-12-12	1996-11-19	Allelix Biopharmaceuticals Inc.	Bicyclic nonane and decane compounds having dopamine receptor affinity

1996
- 1996-11-06 CZ CZ981929A patent/CZ192998A3/cs unknown
- 1996-11-06 ES ES96935226T patent/ES2161377T3/es not_active Expired - Lifetime
- 1996-11-06 AT AT96935226T patent/ATE205846T1/de not_active IP Right Cessation
- 1996-11-06 DE DE69615404T patent/DE69615404T2/de not_active Expired - Fee Related
- 1996-11-06 BR BR9612246A patent/BR9612246A/pt not_active Application Discontinuation
- 1996-11-06 IL IL12445396A patent/IL124453A0/xx unknown
- 1996-11-06 HU HU9900611A patent/HUP9900611A3/hu unknown
- 1996-11-06 WO PCT/IB1996/001192 patent/WO1997023482A1/en not_active Ceased
- 1996-11-06 RU RU98111742/04A patent/RU2162470C2/ru not_active IP Right Cessation
- 1996-11-06 DK DK96935226T patent/DK0874849T3/da active
- 1996-11-06 EP EP96935226A patent/EP0874849B1/en not_active Expired - Lifetime
- 1996-11-06 CN CN96199250A patent/CN1061350C/zh not_active Expired - Fee Related
- 1996-11-06 PT PT96935226T patent/PT874849E/pt unknown
- 1996-11-06 PL PL96327539A patent/PL327539A1/xx unknown
- 1996-11-06 SI SI9630343T patent/SI0874849T1/xx unknown
- 1996-11-06 KR KR1019980704718A patent/KR100286786B1/ko not_active Expired - Fee Related
- 1996-11-06 JP JP52344697A patent/JP3204456B2/ja not_active Expired - Fee Related
- 1996-11-06 TR TR1998/01161T patent/TR199801161T2/xx unknown
- 1996-11-06 NZ NZ320537A patent/NZ320537A/xx unknown
- 1996-11-06 CA CA002240594A patent/CA2240594C/en not_active Expired - Fee Related
- 1996-11-06 AU AU73280/96A patent/AU704578B2/en not_active Ceased
- 1996-11-08 TW TW085113669A patent/TW479058B/zh not_active IP Right Cessation
- 1996-12-16 AR ARP960105715A patent/AR005102A1/es not_active Application Discontinuation
- 1996-12-16 PE PE1996000913A patent/PE25998A1/es not_active Application Discontinuation
- 1996-12-18 TN TNTNSN96164A patent/TNSN96164A1/fr unknown
- 1996-12-18 MA MA24432A patent/MA26413A1/fr unknown
- 1996-12-19 GT GT199600101A patent/GT199600101A/es unknown
- 1996-12-20 CO CO96066997A patent/CO4480107A1/es unknown
- 1996-12-20 ZA ZA9610781A patent/ZA9610781B/xx unknown
- 1996-12-23 US US08/774,290 patent/US5714487A/en not_active Expired - Fee Related
1998
- 1998-06-19 NO NO982843A patent/NO309936B1/no unknown
- 1998-06-22 MX MX9805088A patent/MX9805088A/es unknown
2001
- 2001-10-30 GR GR20010401932T patent/GR3037060T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2161377T3 (es)	2001-12-01
PT874849E (pt)	2002-01-30
GR3037060T3 (en)	2002-01-31
AU7328096A (en)	1997-07-17
TW479058B (en)	2002-03-11
CN1205704A (zh)	1999-01-20
KR100286786B1 (ko)	2001-04-16
RU2162470C2 (ru)	2001-01-27
US5714487A (en)	1998-02-03
DE69615404D1 (de)	2001-10-25
ATE205846T1 (de)	2001-10-15
AR005102A1 (es)	1999-04-14
CA2240594C (en)	2001-07-24
ZA9610781B (en)	1998-06-22
CA2240594A1 (en)	1997-07-03
PL327539A1 (en)	1998-12-21
PE25998A1 (es)	1998-05-19
CZ192998A3 (cs)	1999-05-12
BR9612246A (pt)	1999-07-13
AU704578B2 (en)	1999-04-29
MX9805088A (es)	1998-10-31
HUP9900611A3 (en)	2000-09-28
NZ320537A (en)	1999-03-29
TNSN96164A1 (fr)	2005-03-15
MA26413A1 (fr)	2004-12-20
DK0874849T3 (da)	2001-11-19
KR19990076616A (ko)	1999-10-15
EP0874849A1 (en)	1998-11-04
EP0874849B1 (en)	2001-09-19
JPH11508920A (ja)	1999-08-03
NO982843D0 (no)	1998-06-19
CO4480107A1 (es)	1997-07-09
TR199801161T2 (xx)	1998-10-21
DE69615404T2 (de)	2002-06-06
NO309936B1 (no)	2001-04-23
SI0874849T1 (no)	2001-12-31
WO1997023482A1 (en)	1997-07-03
CN1061350C (zh)	2001-01-31
JP3204456B2 (ja)	2001-09-04
HUP9900611A2 (hu)	1999-08-30
GT199600101A (es)	1998-06-12
IL124453A0 (en)	1998-12-06

Publication	Publication Date	Title
NO974595D0 (no)	1997-10-03	Imidazo£1,2-a\|pyridin-derivater
NL300214I1 (nl)	2006-03-01	Chinazolinederivaten.
DE69611361D1 (de)	2001-02-01	Chinazolin-derivate
NO974103L (no)	1997-11-05	Arylsulfonylaminohydroksamsyre-derivater
DE69610698D1 (de)	2000-11-23	Chinazolin-derivate
TR199600883A2 (tr)	1997-05-21	Pürin-6-on türevleri.
ATE199150T1 (de)	2001-02-15	Diphenylmethylenpiperidin-derivate
NO982843D0 (no)	1998-06-19	2,7-Substituerte oktahydro-pyrrol£1,2-a\|pyrazin-derivater
DE69601527D1 (de)	1999-03-25	Pyrrolylbenzimidazol-Derivate
ATA100695A (de)	1998-03-15	Prothrombin-derivate
TR199600715A2 (tr)	1997-03-21	Kefalosforin türevleri.
FI971310L (fi)	1997-03-27	2,7-substituoituja oktahydro-1H-pyrido/1,2-a/pyratsiinijohdannaisia
ATE240307T1 (de)	2003-05-15	Diarylalkenylamin-derivate
DE69627830D1 (de)	2003-06-05	Pyrazol-derivate
TR199600064A2 (tr)	1996-08-21	4-amino-benzoilguanidin-türevleri.
DE59610106D1 (de)	2003-03-13	Fluorbenzylether-Derivate
ATE177102T1 (de)	1999-03-15	Chromanderivate
DE69624122D1 (de)	2002-11-07	Aza-anthracyclinone-derivate
BR9603508A (pt)	1998-05-12	Derivados de alquenil-benzoilguanidina
ATE202088T1 (de)	2001-06-15	4-mercapto-benzoylguanidin-derivate
DE69620514D1 (de)	2002-05-16	5-aminoflavon-derivate
BR9609892A (pt)	1999-05-25	Derivados de imidazopiridina
ATA45796A (de)	1999-09-15	Lysin-prolin-derivate
FI970827L (fi)	1997-02-27	Uudet tiatsolo 3,2-a/kinoliini - ja -nafthyridiinijohdannaiset
BR9603253A (pt)	1998-04-28	Derivados de camptotecina